Study finds big drop in COVID antibodies within four months of vaccination in India

By: |
September 15, 2021 4:38 PM

British researchers said last month that protection offered by two doses of the Pfizer/BioNTech and the AstraZeneca vaccines begins to fade within six months.

"significant" drop in their COVID-fighting antibodies , provide booster doses, COVID cases and deaths in India , Regional Medical Research Centre, Pfizer/BioNTech and the AstraZeneca vaccinesBritish researchers said last month that protection offered by two doses of the Pfizer/BioNTech and the AstraZeneca vaccines begins to fade within six months.

A study of 614 fully vaccinated health workers in India found a “significant” drop in their COVID-fighting antibodies within four months of the first shot. The findings could help the Indian government decide whether to provide booster doses as some Western countries tegy-under-winter-plan-2021-09-13 have done.

Waning antibodies do not necessarily mean that immunised people lose their ability to counter the disease, as the body’s memory cells may still kick in to offer substantial protection, said the director of a state-run institute that did the study.

“After six months, we should be able to tell you more clearly whether and when a booster would be needed,” Sanghamitra Pati of the Regional Medical Research Centre, based in the eastern city of Bhubaneswar, told Reuters on Tuesday. “And we would urge similar studies in different areas for pan-India data.”

British researchers said last month that protection offered by two doses of the Pfizer/BioNTech and the AstraZeneca vaccines begins to fade within six months. The Indian study, published in the Research Square pre-print platform but yet to be peer reviewed, is one of the first such done in the country involving its main two vaccines – Covishield, a licensed version of the AstraZeneca shot, and domestically developed Covaxin.

Health officials say though they are studying the evolving science on booster doses, the priority is to fully immunise India’s 944 million adults. More than 60% of them have received at least one dose and 19% the required two doses.

COVID cases and deaths in India have come down sharply since a peak of more than 400,000 infections in early May. India has reported 33.29 million cases in total and 443,213 deaths.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, Check out latest IPO News, Best Performing IPOs, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1Is the delta variant of the coronavirus worse for kids?
2Coronavirus (Covid-19) India Live News: Union Health Minister Mandaviya releases latest guidelines on post-COVID management
3Covid-19 vaccine: Centre files plea against allowing 2nd dose of Covishield earlier, says it will derail policy